Welcome to the brave new world of local deals, where marketers are trying to drive people online to buy offline. Read on to know three key things that set this market apart.
The investment momentum in Indian start-ups rocketed over the past five years. PE activity in 2015 touched an all-time high - investments totalled 1,049, over 600 of them in start-ups. The stars of Indian e-commerce became super stars.
It is like a chat/messaging app that can be used across multiple platforms and devices, with features such as one-to-one and group messaging, file sharing plus integration into several popular apps and web services.
The declining efficacy of responses notwithstanding, the rising popularity and increasing awareness of RTI shows it is here to stay. Experts believe the act is strong enough to withstand any attempts to throttle it, but information commissioners need to be firm.
Have great ideas but lack deep pockets? Pitch your ideas on crowdfunding platforms and let the people get your ideas off the ground.
Declutter your SMS inbox or add a dash of perfection to your pictures with these easy-to-use apps.
What Indian manufacturing can learn from Monozukuri - the latest import from Nippon.
This memoir of the author's time as India's chief economic adviser is loaded with lessons in economics and has fascinating stories.
The India Today Conclave of 2016 got off to a roaring start with a discussion between Union Minister of Finance Arun Jaitley and a group of leading economic thinkers.
Two power-packed panels met for a brainstorming session at the BT Knowledge Forum on HR in Pune.
Gautam Adani's port empire has expanded dramatically in the past decade. But it also faces challenges.
Investors hoping for better days must be cautious.
After weeks of public outcry and intense media scrutiny, embattled UB Group Chairman Vijay Mallya has made an offer to settle outstanding loans of his now defunct Kingfisher Airlines (KFA). The bank consortium may find it hard to accept Mallya's offer for a couple of reasons.
The unexpected government ban on FDCs has Indian pharma companies scurrying to courts.
Battlelines getting drawn between local biotech firms and MNCs over the new guidelines on biosimilars.
"Persistency is a concern in the Indian market"